NEW BRUNSWICK, N.J., Jan. 27, 2017 /PRNewswire/ -- Natreon,Inc. has filed a lawsuit against Ixoreal Biomed Inc, Los Angeles, CA ("Ixoreal Biomed'), marketer of KSM-66 ashwagandha, and its parent company, Shri Kartikeya Pharma, Ltd., Hyderabad, India ("SKP"). The complaint, filed on September 30, 2016, alleges false advertising, trade libel, defamation, and tortious interference, among other counts.
Notably, one of the most serious claims leveled against the companies is that KSM-66 contains undeclared milk allergens, thus posing a serious public health risk. Natreon has gotten a total of 34 products from the market containing KSM-66 tested, out of which 16 products tested positive for milk allergens. 13 of these products did not declare the presence of milk allergens on their labels, and 3 products in fact declared to be dairy free. Two of the products which tested positive are two different lots of KSM-66 pure powder, repackaged and sold. Interestingly, some products containing KSM-66 declared the presence of milk allergens, while many did not. Out of the 16 products which tested positive, four contained Organic KSM-66, and two of them declared no dairy. Three different reputed labs in USA were used to test the products.
The results have been forwarded to U.S. Food and Drug Administration ("FDA"). Milk allergens are one of the 8 allergens for which the FDA has zero tolerance.
About Natreon, Inc
Natreon Inc. is an 18 year old company located in New Jersey with a state of the art R&D facility in Kolkata, India, and is focused on developing and marketing Ayurvedic products backed by extensive research, high degree of standardization, multiple clinical studies, safety studies, and intellectual property. Natreon's R&D team is headed by Prof. Shibnath Ghosal, a Fulbright scholar and an eminent natural product chemist with hundreds of publications in scientific journals and a group of Ph.D. and Master's level scientists. Natreon's scientific research includes process optimization, development of chromatographic analytical methods such as HPLC, HPTLC, GC-MS and LC-MS for standardization, development of marker compounds, and pharmacological studies. Safety studies are done in the USA and clinical studies are conducted in reputed institutes in India as well as the USA.
For more information on Natreon's patented ingredients, please visit www.natreoninc.com.
SOURCE Natreon, Inc.